158 related articles for article (PubMed ID: 38753091)
21. Integrated analysis identifies a novel lncRNA prognostic signature associated with aerobic glycolysis and hub pathways in breast cancer.
Li Z; Zheng J; Feng Y; Li Y; Liang Y; Liu Y; Wang X; Yang Q
Cancer Med; 2021 Nov; 10(21):7877-7892. PubMed ID: 34581026
[TBL] [Abstract][Full Text] [Related]
22. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
[TBL] [Abstract][Full Text] [Related]
23. Construction of a prognostic model for breast cancer based on moonlighting genes.
Zhang M; Zhang D; Wang Q; Lin G
Hum Mol Genet; 2024 Jun; 33(12):1023-1035. PubMed ID: 38491801
[TBL] [Abstract][Full Text] [Related]
24. Development of prognostic signature and nomogram for patients with breast cancer.
Su J; Miao LF; Ye XH; Cui MS; He XF
Medicine (Baltimore); 2019 Mar; 98(11):e14617. PubMed ID: 30882627
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of autophagy-related prognostic genes in breast cancer.
Lai J; Chen B; Mok H; Zhang G; Ren C; Liao N
J Cell Mol Med; 2020 Aug; 24(16):9145-9153. PubMed ID: 32618109
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
27. Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature.
Shen L; Huang H; Li J; Chen W; Yao Y; Hu J; Zhou J; Huang F; Ni C
Front Immunol; 2023; 14():1199465. PubMed ID: 37469520
[TBL] [Abstract][Full Text] [Related]
28. Integrative analysis of multi-omics data reveals a pseudouridine-related lncRNA signature for prediction of glioma prognosis and chemoradiotherapy sensitivity.
Yang Y; Wang F; Teng H; Zhang C; Zhang Y; Chen P; Li Q; Kan X; Chen Z; Wang Z; Yu Y
Comput Biol Med; 2023 Nov; 166():107428. PubMed ID: 37748218
[TBL] [Abstract][Full Text] [Related]
29. A pyroptosis-related gene signature predicting survival and tumor immune microenvironment in breast cancer and validation.
Gong M; Liu X; Zhao X; Wang H
BMC Cancer; 2022 Sep; 22(1):1005. PubMed ID: 36138348
[TBL] [Abstract][Full Text] [Related]
30. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer.
Liang J; Wang X; Yang J; Sun P; Sun J; Cheng S; Liu J; Ren Z; Ren M
Front Immunol; 2023; 14():1198826. PubMed ID: 38035071
[TBL] [Abstract][Full Text] [Related]
31. Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models.
Li L; Liu ZP
J Transl Med; 2021 Dec; 19(1):514. PubMed ID: 34930307
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive Characterization of the Function of Metabolic Genes and Establishment of a Prediction Model in Breast Cancer.
Yu R; Peng M; Zhao S; Wang Z; Ma Y; Zhang X; Lv X; Wang S; Ju S; Zhao R; Zhou Q; Lian W
Dis Markers; 2022; 2022():3846010. PubMed ID: 35493305
[TBL] [Abstract][Full Text] [Related]
33. A signature constructed with mitophagy-related genes to predict the prognosis and therapy response for breast cancer.
Zhao Y; Zhang Y; Dai C; Hong K; Guo Y
Aging (Albany NY); 2022 Aug; 14(15):6169-6186. PubMed ID: 35939339
[TBL] [Abstract][Full Text] [Related]
34. Identification of a pyroptosis-related prognostic signature in breast cancer.
Chen H; Luo H; Wang J; Li J; Jiang Y
BMC Cancer; 2022 Apr; 22(1):429. PubMed ID: 35443644
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of a metabolism-related gene signature for the prognosis of colorectal cancer: a multicenter cohort study.
Han P; Yang X; Li L; Bao J; Zhang W; Zai S; Zhu Z; Wu M
Jpn J Clin Oncol; 2022 Nov; 52(11):1327-1336. PubMed ID: 35848857
[TBL] [Abstract][Full Text] [Related]
36. Identification and Prognostic Value Exploration of Cyclophosphamide (Cytoxan)-Centered Chemotherapy Response-Associated Genes in Breast Cancer.
Du J; Dong Y; Li Y
DNA Cell Biol; 2021 Nov; 40(11):1356-1368. PubMed ID: 34704810
[TBL] [Abstract][Full Text] [Related]
37. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
38. The Pyroptosis-Related Risk Genes APOBEC3D, TNFRSF14, and RAC2 Were Used to Evaluate Prognosis and as Tumor Suppressor Genes in Breast Cancer.
Chen Q; Jun H; Yang C; Yang F; Xu Y
J Oncol; 2022; 2022():3625790. PubMed ID: 36059808
[TBL] [Abstract][Full Text] [Related]
39. A novel signature incorporating genes related to lipid metabolism and immune for prognostic and functional prediction of breast cancer.
Zhao X; Yan L; Yang Z; Zhang H; Kong L; Zhang N; He Y
Aging (Albany NY); 2024 May; 16(10):8611-8629. PubMed ID: 38771140
[TBL] [Abstract][Full Text] [Related]
40. A 17-gene expression-based prognostic signature associated with the prognosis of patients with breast cancer: A STROBE-compliant study.
Qian JX; Yu M; Sun Z; Jiang AM; Long B
Medicine (Baltimore); 2020 Apr; 99(15):e19255. PubMed ID: 32282693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
